Advances in transcranial magnetic stimulation (TMS) and its applications in resistant depression

Theodoros Koutsomitros; Olympia Evagorou; Teresa Schuhmann; Antonis Zamar; Alexander T. Sack

doi:10.22365/jpsych.2021.054

Advances in transcranial magnetic stimulation (TMS) and its applications in resistant depression

Theodoros Koutsomitros^*, Olympia Evagorou, Teresa Schuhmann, Antonis Zamar, Alexander T. Sack

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

Transcranial magnetic stimulation (TMS) is a non-invasive method of brain stimulation that is receiving increasingly attentionTranscranial magnetic stimulation (TMS) is a non-invasive method of brain stimulation that is receiving increasingly attentionfor new clinical applications. Through electromagnetic induction cortical activity can be modulated and therapeuticeffects can be achieved in a variety of psychiatric and neurological conditions. According to the World Health Organization(WHO) depression is the most disabling disease in the world and 350 million people suffer from depression globally. Majordepression is the most common disorder to be treated with TMS and the first mental disorder for which TMS received approvalfrom the US Food and Drug Administration (FDA). We here introduce the basic principles of TMS, discuss the latestdata on safety and side effects, and present various TMS treatment protocols as well as treatment response predictors inmajor depressive disorder.

Original language	English
Pages (from-to)	90-98
Number of pages	9
Journal	Psychiatriki
Volume	32
Issue number	Supplement I
DOIs	https://doi.org/10.22365/jpsych.2021.054
Publication status	Published - Dec 2021

Keywords

Depression
Depressive Disorder, Major/therapy
Humans
Prefrontal Cortex
Transcranial Magnetic Stimulation

Access to Document

10.22365/jpsych.2021.054

Cite this

@article{cae314c725984a24bf6ac3ff6cae4211,

title = "Advances in transcranial magnetic stimulation (TMS) and its applications in resistant depression",

abstract = "Transcranial magnetic stimulation (TMS) is a non-invasive method of brain stimulation that is receiving increasingly attentionTranscranial magnetic stimulation (TMS) is a non-invasive method of brain stimulation that is receiving increasingly attentionfor new clinical applications. Through electromagnetic induction cortical activity can be modulated and therapeuticeffects can be achieved in a variety of psychiatric and neurological conditions. According to the World Health Organization(WHO) depression is the most disabling disease in the world and 350 million people suffer from depression globally. Majordepression is the most common disorder to be treated with TMS and the first mental disorder for which TMS received approvalfrom the US Food and Drug Administration (FDA). We here introduce the basic principles of TMS, discuss the latestdata on safety and side effects, and present various TMS treatment protocols as well as treatment response predictors inmajor depressive disorder.",

keywords = "Depression, Depressive Disorder, Major/therapy, Humans, Prefrontal Cortex, Transcranial Magnetic Stimulation",

author = "Theodoros Koutsomitros and Olympia Evagorou and Teresa Schuhmann and Antonis Zamar and Sack, {Alexander T.}",

year = "2021",

month = dec,

doi = "10.22365/jpsych.2021.054",

language = "English",

volume = "32",

pages = "90--98",

journal = "Psychiatriki",

issn = "1105-2333",

publisher = "Hellenic Psychiatric Association",

number = "Supplement I",

}

TY - JOUR

T1 - Advances in transcranial magnetic stimulation (TMS) and its applications in resistant depression

AU - Koutsomitros, Theodoros

AU - Evagorou, Olympia

AU - Schuhmann, Teresa

AU - Zamar, Antonis

AU - Sack, Alexander T.

PY - 2021/12

Y1 - 2021/12

N2 - Transcranial magnetic stimulation (TMS) is a non-invasive method of brain stimulation that is receiving increasingly attentionTranscranial magnetic stimulation (TMS) is a non-invasive method of brain stimulation that is receiving increasingly attentionfor new clinical applications. Through electromagnetic induction cortical activity can be modulated and therapeuticeffects can be achieved in a variety of psychiatric and neurological conditions. According to the World Health Organization(WHO) depression is the most disabling disease in the world and 350 million people suffer from depression globally. Majordepression is the most common disorder to be treated with TMS and the first mental disorder for which TMS received approvalfrom the US Food and Drug Administration (FDA). We here introduce the basic principles of TMS, discuss the latestdata on safety and side effects, and present various TMS treatment protocols as well as treatment response predictors inmajor depressive disorder.

AB - Transcranial magnetic stimulation (TMS) is a non-invasive method of brain stimulation that is receiving increasingly attentionTranscranial magnetic stimulation (TMS) is a non-invasive method of brain stimulation that is receiving increasingly attentionfor new clinical applications. Through electromagnetic induction cortical activity can be modulated and therapeuticeffects can be achieved in a variety of psychiatric and neurological conditions. According to the World Health Organization(WHO) depression is the most disabling disease in the world and 350 million people suffer from depression globally. Majordepression is the most common disorder to be treated with TMS and the first mental disorder for which TMS received approvalfrom the US Food and Drug Administration (FDA). We here introduce the basic principles of TMS, discuss the latestdata on safety and side effects, and present various TMS treatment protocols as well as treatment response predictors inmajor depressive disorder.

KW - Depression

KW - Depressive Disorder, Major/therapy

KW - Humans

KW - Prefrontal Cortex

KW - Transcranial Magnetic Stimulation

U2 - 10.22365/jpsych.2021.054

DO - 10.22365/jpsych.2021.054

M3 - Article

C2 - 34990384

SN - 1105-2333

VL - 32

SP - 90

EP - 98

JO - Psychiatriki

JF - Psychiatriki

IS - Supplement I

ER -